
We’re on a mission to enable effective therapies to people faster.
A novel approach to research
For the past two decades clinical research has been hindered by outdated processes and technologies leaving millions without treatments.
After struggling to access patients in her own research in rare skin diseases, Dr. Michelle Longmire set out to solve this long-standing challenge in research.
Drawing inspiration from innovation and technological advancements in other industries, Longmire rallied stakeholders, partners, and developers to launch our company, Medable, with the shared vision of radically increasing the number of effective therapies to people each year.
Committed to science. Powered by innovation.
In order to achieve this vision, we needed to amplify the quality, reach, velocity, and cost of research.
Driven by the belief that clinical research can and should be better, we've assembled world-class scientific and product teams to continuously drive evidence-based improvements to the trial experience for all.
The relentless pursuit of progress, together.
Human connection is at the heart of everything we do. We prioritize the personal experience of patients, caregivers, knowing that their knowledge and feedback are essential to improving clinical research. In close partnership with with our network of sites, we continuously improve our platform, because we know that when they win, we all win. By designing products that are more accessible and user-friendly, we can bring life-change treatments to those who need them faster.
Together, with our clients and partners, we continue to work toward our mission and drive clinical research forward for the betterment of all.
Accolades





The latest from Medable


The Definitive Guide to Digital Evidence Generation
According to Grandview Research, the hybrid and decentralized clinical trial (DCT) market will be worth more than 12 billion dollars by 2030. Sparked by the COVID-19 pandemic of 2020, the rapid ascent of patient-centered technology and the digital and decentralized trials they’ve spawned has forever changed the landscape of clinical conduct. Sponsors are increasingly turning to DCT platforms in alignment with the rise of Life Science and Software-as-a-Service (SaaS) solutions. For those who haven't made the jump yet, there are many questions, including "What is a decentralized clinical trial?" Find out with this in-depth guide to decentralized clinical trials. Uncover how they work, their benefits, and how they transform clinical development.


Medable Ranks in Top 8% of 2023 Inc. 5000 List of America’s Fastest-Growing Private Companies
Medable, the leading technology provider for patient-centric clinical trials, today announced that it ranked in the top 8 percent (#398) and was one of the top 50 software companies on the 2023 Inc. 5000, its annual list of the fastest-growing private companies in America. Medable’s ranking was fueled by its strong three-year growth rate of 1,453% from 2019 through 2022.


MRCT Center and Medable Launch First, Comprehensive IRB/EC Review Toolkit for Decentralized Clinical Trials
MRCT Center and Medable launch first-of-its-kind toolkit to provide a common framework, tools, and best practices for uniform ethical review and approval to simplify, streamline, and speed the IRB/EC process – a key step towards more efficient, patient-centered research execution.